Nwagbologu Nwamaka, Sarangarm Preeyaporn, D'Angio Richard
Hosp Pharm. 2016 Oct;51(9):730-737. doi: 10.1310/hpj5109-730.
: Postoperative pain is managed with opioids, which are associated with adverse effects. The efficacy of intravenous (IV) acetaminophen in reducing opioid consumption has been studied with inconsistent results. The primary outcome of this study was to assess the effect of IV acetaminophen on opioid consumption 24 hours postoperatively. Secondary outcomes included the opiate consumption at 48 hours after the operation, opioid-related side effects 72 hours after the operation, discharge disposition, and length of stay. This was an IRB-approved, retrospective cohort study including adult patients who underwent an elective total knee arthroplasty (TKA). Patients were stratified into IV and no IV acetaminophen groups; patients who had received at least one dose of IV acetaminophen were included in the IV acetaminophen group. Total opioids were collected, converted to morphine equivalents, and compared between groups. Patients were excluded for alcohol abuse, substance abuse treatment, non-elective TKA, or medication mischarting. : Of the 161 patients evaluated, 148 patients were included: 86 in the IV acetaminophen and 62 in the no IV acetaminophen group. There were no differences in mean morphine equivalents between groups postoperatively at 24 hours (54.2 ± 35.9 mg vs 45.4 ± 30.2 mg; = .12) and 48 hours (99.2 ± 68.7 mg vs 79.5 ± 49.1 mg; = .06). There were no differences in secondary outcomes (administration of bowel regimen medications, antiemetics, naloxone, discharge disposition, or length of stay) between the groups. : The use of IV acetaminophen was not associated with a decrease in opiate use, opiate-related side effects, or any secondary outcomes in patients who underwent TKA.
术后疼痛通过阿片类药物控制,而阿片类药物存在不良反应。静脉注射对乙酰氨基酚减少阿片类药物用量的疗效已有研究,但结果并不一致。本研究的主要结局是评估静脉注射对乙酰氨基酚对术后24小时阿片类药物用量的影响。次要结局包括术后48小时的阿片类药物用量、术后72小时与阿片类药物相关的副作用、出院情况及住院时间。这是一项经机构审查委员会批准的回顾性队列研究,纳入接受择期全膝关节置换术(TKA)的成年患者。患者被分为静脉注射对乙酰氨基酚组和未使用静脉注射对乙酰氨基酚组;接受过至少一剂静脉注射对乙酰氨基酚的患者纳入静脉注射对乙酰氨基酚组。收集总阿片类药物用量,换算为吗啡当量,并在组间进行比较。因酗酒、药物滥用治疗、非择期TKA或用药错误而排除患者。在161例接受评估的患者中,148例被纳入研究:静脉注射对乙酰氨基酚组86例,未使用静脉注射对乙酰氨基酚组62例。两组术后24小时(54.2±35.9毫克对45.4±30.2毫克;P=0.12)和48小时(99.2±68.7毫克对79.5±49.1毫克;P=0.06)的平均吗啡当量无差异。两组间次要结局(肠道调节药物、止吐药、纳洛酮的使用、出院情况或住院时间)也无差异。接受TKA的患者使用静脉注射对乙酰氨基酚与阿片类药物使用减少、阿片类药物相关副作用或任何次要结局均无关。